[The effect of prolonged acenocoumarol therapy on bone density].
The effect of chronic cumarin treatment on bone mineral content was investigated. Bone mineral density was determined by double photon densitometry (Lunar DPXL). The density data (mean +/- SE) of 45 cardiac patients (age: 57.0 = +/- 6.3 y, body mass index: 26.7 +/- 3.8 kp/m2, cardiac stadium score, according to New York Heart Association: 2-3), had been treated by acenocumarol at least for 2 years (duration of treatment: 75.0 +/- 52 months), were compared to the values of 45 age, body mass index, cardiac status matched patients not treated by anticoagulant. The density values of L2-L4 lumbar regions were lower in the treated group (1.041 +/- 0.17 vs. controlls: 1.13 +/- 0.15 g/cm2, p < 0.05), while no differences in ultradistal ulnar and radial regions were detected. No correlation between bone mineral density and the length, or the dose of the cumarin treatment were observed. This observation suggests the importance of the regular bone densitometry control of cumarin treated patient.
Kiss
J
J
Dunántúli Osteoporosis Decentrum, Allami Szívkórház, Balatonfüred.
Tihanyi
L
L
Nagy
E
E
Végh
Z
Z
Deli
A
A
Tahy
A
A
Korányi
L
L
D000074:Acenocoumarol / Q000008:administration & dosage* / Q000009:adverse effects; D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D015519:Bone Density / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D006814:Hungary; D008297:Male; D008875:Middle Aged
D000925:Anticoagulants; D000074:Acenocoumarol
A tartós acenocumarol kezelés hatása a csonttömegre.